Elanco Animal Health Debt-to-Equity Ratio Growth & History (ELAN)
Elanco Animal Health's debt-to-equity ratio was 0.63 for fiscal 2025.
View full Elanco Animal Health company overviewElanco Animal Health annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.63 | −0.10 | −13.24% |
| 2024 | 2024-12-31 | 0.73 | −0.22 | −23.32% |
| 2023 | 2023-12-31 | 0.95 | 0.13 | +15.92% |
| 2022 | 2022-12-31 | 0.82 | −0.04 | −4.98% |
| 2021 | 2021-12-31 | 0.86 | 0.12 | +15.58% |
| 2020 | 2020-12-31 | 0.75 | 0.31 | +69.62% |
| 2019 | 2019-12-31 | 0.44 | −0.04 | −7.45% |
| 2018 | 2018-12-31 | 0.48 | 0.48 | — |
| 2017 | 2017-12-31 | 0.00 | — | — |
Elanco Animal Health quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.59 | −0.03 | −4.27% |
| Q1 2026 | 2026-03-31 | 0.61 | −0.08 | −11.25% |
| Q4 2025 | 2025-12-31 | 0.63 | −0.10 | −13.24% |
| Q3 2025 | 2025-09-30 | 0.60 | −0.07 | −10.74% |
| Q2 2025 | 2025-06-30 | 0.62 | −0.33 | −34.96% |
| Q1 2025 | 2025-03-31 | 0.69 | −0.26 | −27.33% |
| Q4 2024 | 2024-12-31 | 0.73 | −0.22 | −23.32% |
| Q3 2024 | 2024-09-30 | 0.67 | −0.30 | −30.66% |
| Q2 2024 | 2024-06-30 | 0.96 | 0.14 | +16.92% |
| Q1 2024 | 2024-03-31 | 0.95 | 0.15 | +18.28% |
| Q4 2023 | 2023-12-31 | 0.95 | 0.13 | +15.92% |
| Q3 2023 | 2023-09-30 | 0.96 | 0.08 | +9.60% |
| Q2 2023 | 2023-06-30 | 0.82 | −0.03 | −3.99% |
| Q1 2023 | 2023-03-31 | 0.80 | −0.00 | −0.48% |
| Q4 2022 | 2022-12-31 | 0.82 | −0.04 | −4.98% |
| Q3 2022 | 2022-09-30 | 0.88 | 0.05 | +6.60% |
| Q2 2022 | 2022-06-30 | 0.85 | 0.09 | +11.38% |
| Q1 2022 | 2022-03-31 | 0.81 | 0.04 | +5.10% |
| Q4 2021 | 2021-12-31 | 0.86 | 0.12 | +15.58% |
| Q3 2021 | 2021-09-30 | 0.82 | 0.09 | +12.05% |
| Q2 2021 | 2021-06-30 | 0.76 | 0.45 | +147.16% |
| Q1 2021 | 2021-03-31 | 0.77 | 0.46 | +148.61% |
| Q4 2020 | 2020-12-31 | 0.75 | 0.31 | +69.62% |
| Q3 2020 | 2020-09-30 | 0.74 | 0.29 | +65.38% |
| Q2 2020 | 2020-06-30 | 0.31 | −0.16 | −34.65% |
| Q1 2020 | 2020-03-31 | 0.31 | −0.18 | −36.85% |
| Q4 2019 | 2019-12-31 | 0.44 | −0.04 | −7.45% |
| Q3 2019 | 2019-09-30 | 0.44 | −0.04 | −7.77% |
| Q2 2019 | 2019-06-30 | 0.47 | — | — |
| Q1 2019 | 2019-03-31 | 0.49 | — | — |
| Q4 2018 | 2018-12-31 | 0.48 | 0.48 | — |
| Q3 2018 | 2018-09-30 | 0.48 | — | — |
| Q4 2017 | 2017-12-31 | 0.00 | — | — |
Elanco Animal Health debt-to-equity ratio trends
Over the last five fiscal years, Elanco Animal Health's debt-to-equity ratio decreased from 0.75 to 0.63, a change of −0.11. The latest reported quarter, Q2 2026, shows 0.59.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Elanco Animal Health source filings ↗